Evidence map›Paper›PMID 41122601›Full record

ArticleCureus2025

Emerging Antifungal Resistance in Dermatophytosis: A Clinicomycological Study From North India.

Anushka Lohariwala, Sanjeev Gupta, Narinder Kaur, Aneet Mahendra

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anushka LohariwalaDermatology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Ambala, IND.
Sanjeev GuptaDermatology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Ambala, IND.
Narinder KaurMicrobiology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Ambala, IND.
Aneet MahendraDermatology, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Ambala, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Dermatophytosis is a common superficial fungal infection affecting the skin, hair, and nails and is increasingly being recognized as a public health challenge. In recent years, there has been a noticeable increase in chronic and recurrent cases, possibly due to changing patterns of antifungal resistance, misuse of medications, and host-related factors. This study aimed to assess the demographic and clinical characteristics of patients with dermatophytosis, evaluate treatment history and recurrence, and analyze antifungal resistance patterns. Material and methods A total of 130 patients clinically diagnosed with dermatophytosis and attending the Dermatology Outpatient Department were included in this observational study. After obtaining informed consent, detailed data on demographic factors, clinical presentation using the Dermatophytosis Severity Score (DSS), treatment history, and recurrence were recorded. Fungal cultures and antifungal susceptibility testing were performed on positive isolates to evaluate resistance patterns. Results The most affected age group was 31-45 years (38; 42.2%), with a male predominance (52; 57.8%). Most patients were rural residents (72; 80%) and uneducated (58; 64.4%), with homemakers (32; 35.6%) and students (19; 21.1%) forming the major occupational groups. Disease duration was mostly one to two years (40; 44.4%), and recurrent infections were common (83; 92.2%), even with mild severity scores (DSS 1-10 in 79 individuals; 87.8%).

Indexed as

antifungal resistancechronic dermatophytosisclinical dermatologykohtinea infections

Identifiers

PMID41122601
PMCPMC12536753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.